Circulating cell-free (cf)DNA analysis: Current technologies and applications in gynecologic cancer
Cell-free DNA (cfDNA) analysis has several promising clinical applications in the management of cancer patients, with clinical validity established in different types of solid tumors (e.g., lung, breast, and colon cancer). Cancers harbor unique genetic alterations that can be detected in the plasma...
Saved in:
Main Authors: | Sarah H Kim (Author), Britta Weigelt (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value
by: Anna Citarella, et al.
Published: (2023) -
cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
by: Elodie Bohers, et al.
Published: (2021) -
Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017) -
Circulating cell-free DNA biomarkers
by: Jose Rafael Villarreal Escorcia
Published: (2021) -
Detection Cell-Free DNA (cfDNA) Using Nested-PCR as a Diagnosis Tool for Human Fascioliasis Infection
by: Mojgan ARYAEIPOUR, et al.
Published: (2020)